Ketorolac Tromethamine
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00465 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 22 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | headache disorder | KG + DL |
| 2 | rosacea conjunctivitis | KG + DL |
| 3 | trigeminal autonomic cephalalgia | KG + DL |
| 4 | ulcerative proctosigmoiditis | KG + DL |
| 5 | nasopharyngitis | KG + DL |
| 6 | cap polyposis | KG + DL |
| 7 | cutaneous photosensitivity-lethal colitis syndrome | KG + DL |
| 8 | undetermined colitis | KG + DL |
| 9 | allergic urticaria | KG + DL |
| 10 | viral conjunctivitis | KG + DL |
| 11 | frozen shoulder | KG + DL |
| 12 | systemic inflammatory disease associated with an acquired peripheral neuropathy | KG + DL |
| 13 | fasciitis (disease) | KG + DL |
| 14 | glossodynia | KG + DL |
| 15 | osteoarthritis susceptibility | KG + DL |
| 16 | coccygodynia | KG + DL |
| 17 | punctate epithelial keratoconjunctivitis | KG + DL |
| 18 | bursitis | KG + DL |
| 19 | exostosis | KG + DL |
| 20 | common cold | KG + DL |
| 21 | levator syndrome | KG + DL |
| 22 | blepharoconjunctivitis | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.